Literature DB >> 870637

An evaluation of 99mTc-labeled hepatobiliary agents.

B W Wistow, G Subramanian, R L Heertum, R W Henderson, G M Gagne, R C Hall, J G McAfee.   

Abstract

Scintigraphic imaging of the hepatobiliary system has been significantly improved with the development of 99mTc-labeled compounds. Two of the most promising agents, pyridoxylideneglutamate and HIDA, each formed the basis for the development of a group of structural analogs. Condensation of pyridoxal with leucine and arginine (in place of glutamate) produced pyridoxylideneleucine and pyridoxylidenearginine. Since increasing the molecular weight and the lipid solubility of compounds tends to enhance their biliary excretion, several new IDA derivatives were synthesized by altering the lipophilic substituents on the ring of HIDA. The substitutions included ethyl and ethoxy groups as well as iodine. All compounds were compared with 131I-rose bengal using a baboon model that allowed blood, bile, and urine collection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870637

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

1.  Radiology-Epitomes of Progress: Cholescintigraphy: Hepatobiliary Imaging With IDA Derivatives Labeled With Technetium 99m.

Authors:  K F Witztum
Journal:  West J Med       Date:  1981-03

2.  Comparison of two different biliary agents in healthy subjects and in patients with liver disease.

Authors:  R Dudczak; K Kletter; P Angelberger; H Frischauf
Journal:  Eur J Nucl Med       Date:  1979-10

3.  Diagnostic evaluation of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan in acute cholecystitis.

Authors:  T Takada; H Yasuda; K Uchiyama; H Hasegawa; J Shikata; Y Kuniyasu; K Takada
Journal:  Gastroenterol Jpn       Date:  1988-10

4.  The use of 99m Tc-Diethyl-IDA as a liver function test.

Authors:  A Piepsz; H R Ham
Journal:  Eur J Nucl Med       Date:  1980-12

Review 5.  Neonatal obstructive cholangiopathy.

Authors:  D K Bhasin; S Mehta
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

6.  Iodine 131 labelled ioglycamic acid (Biligram) for scintiscanning in hepatobiliary disorders.

Authors:  J N Blackwell; N D Finlayson; G P McLoughlin; M D Sumerling; P Tothill
Journal:  Eur J Nucl Med       Date:  1979-02-01

7.  Hepatobiliary imaging using Tc-pyridoxylideneglutamate in the diagnosis of obstructive jaundice.

Authors:  D N Clarke; P F Sharp; P W Brunt; N A Mowat; G Dascombe; F W Smith
Journal:  Eur J Nucl Med       Date:  1982

8.  Characteristic cholescintigraphic images in space-occupying lesions.

Authors:  F Scopinaro; F Iorio; M Flammia; M Scarpini
Journal:  Eur J Nucl Med       Date:  1982

9.  Asplenia syndrome with atypical cardiac anomalies.

Authors:  W Berman; S M Yabek; J Burstein; T Dillon
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

10.  Body disappearance and liver mean transit time of 99m-Tc-diethyl-IDA.

Authors:  M Taavitsainen; E Riihimäki; E Tähti
Journal:  Eur J Nucl Med       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.